Literature DB >> 7554522

"Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study.

M Timio1, S Venanzi, S Lolli, G Lippi, C Verdura, C Monarca, E Guerrini.   

Abstract

Patients with a blunted or absent nocturnal blood pressure (BP) drop may be subject to increased risk for target organ damage. In this 3-year longitudinal case-control study we tested the hypothesis that an association exists between a reduced or absent night-time fall in BP and a future decline of kidney function in renal hypertensive patients. The case subjects were 48 hypertensives with renal insufficiency, divided into two groups according to the presence (dippers: n 20) or absence (non-dippers: n 28) of a nocturnal diastolic BP decline greater than 10% of daytime values, detected by ambulatory BP monitoring. At the baseline evaluation the two groups did not differ with respect to age, sex, body weight, office systolic and diastolic BP, mean daytime ambulatory BP, creatinine clearance, 24 h proteinuria. In the ambulatory BP profiles over a 3-year follow-up the nocturnal reductions of systolic and diastolic BP in the dippers were 14% and 15%, respectively, vs 7% and 5% in the non-dippers (p = 0.002/0.003). The non-dippers had a faster rate of creatinine clearance decline than the dippers (0.37 +/- 0.26 vs 0.27 +/- 0.09 ml/min/month; p = 0.002). Urinary protein excretion increase was higher in the non-dipper group than in the dipper group (993 +/- 438 vs 691 +/- 222 mg/24 h; p = 0.009). This longitudinal study suggests that the non-dipping pattern of ambulatory BP can be associated with a faster progression of renal insufficiency in renal hypertensives and that a proper nocturnal BP control is an additional aim of antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554522

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  54 in total

Review 1.  Night-time blood pressure patterns and target organ damage: a review.

Authors:  Faye S Routledge; Judith A McFetridge-Durdle; C R Dean
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

2.  Renal resistive index and nocturnal non-dipping: is there an association in essential hypertension?

Authors:  Baris Afsar; Nurhan F Ozdemir; Rengin Elsurer; Siren Sezer
Journal:  Int Urol Nephrol       Date:  2008-09-20       Impact factor: 2.370

Review 3.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 4.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

Review 5.  Understanding the Two Faces of Low-Salt Intake.

Authors:  Branko Braam; Xiaohua Huang; William A Cupples; Shereen M Hamza
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 6.  Ambulatory blood pressure monitoring: from old concepts to novel insights.

Authors:  Mehmet Kanbay; Kultigin Turkmen; Tevfik Ecder; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-07-06       Impact factor: 2.370

Review 7.  Sympathetic nervous system function in renal hypertension.

Authors:  Meryem Tuncel; Robert Augustyniak; Weiguo Zhang; Robert D Toto; Ronald G Victor
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

8.  Office and ambulatory blood pressure elevation in children with chronic renal failure.

Authors:  Mark M Mitsnefes; Thomas R Kimball; Stephen R Daniels
Journal:  Pediatr Nephrol       Date:  2002-12-18       Impact factor: 3.714

Review 9.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 10.  Progression of glomerular and tubular disease in pediatrics.

Authors:  Robert P Woroniecki; H William Schnaper
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.